Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug:141:150-158.
doi: 10.1016/j.rmed.2018.06.030. Epub 2018 Jul 3.

Salvage therapies for refractory hypoxemia in ARDS

Sujith V Cherian  1 , Anupam Kumar  2 , Karunakar Akasapu  3 , Rendell W Ashton  4 , Malaygiri Aparnath  5 , Atul Malhotra  6
Affiliations
Review

Salvage therapies for refractory hypoxemia in ARDS

Sujith V Cherian et al. Respir Med. 2018 Aug.

Abstract

Acute Respiratory Distress Syndrome (ARDS) is a condition of varied etiology characterized by the acute onset (within 1 week of the inciting event) of hypoxemia, reduced lung compliance, diffuse lung inflammation and bilateral opacities on chest imaging attributable to noncardiogenic (increased permeability) pulmonary edema. Although multi-organ failure is the most common cause of death in ARDS, an estimated 10-15% of the deaths in ARDS are caused due to refractory hypoxemia, i.e.- hypoxemia despite lung protective conventional ventilator modes. In these cases, clinicians may resort to other measures with less robust evidence -referred to as "salvage therapies". These include proning, 48 h of paralysis early in the course of ARDS, various recruitment maneuvers, unconventional ventilator modes, inhaled pulmonary vasodilators, and Extracorporeal membrane oxygenation (ECMO). All the salvage therapies described have been associated with improved oxygenation, but with the exception of proning and 48 h of paralysis early in the course of ARDS, none of them have a proven mortality benefit. Based on the current evidence, no salvage therapy has been shown to be superior to the others and each of them is associated with its own risks and benefits. Hence, the order of application of these therapies varies in different institutions and should be applied following a risk-benefit analysis specific to the patient and local experience. This review explores the rationale, evidence, advantages and risks behind each of these strategies.

Keywords: Acute respiratory distress syndrome; Lung; Refractory hypoxemia; Salvage therapies.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Proposed flow chart of management of refractory hypoxemia in moderate-to severe ARDS.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al., Acute respiratory distress syndrome: the Berlin Definition, J. Am. Med. Assoc 307 (23) (2012) 2526–33. - PubMed
    1. Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al., Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries, J. Am. Med. Assoc 315 (8) (2016) 788–800. - PubMed
    1. Cannon JW, Gutsche JT, Brodie D, Optimal strategies for severe acute respiratory distress syndrome, Crit. Care Clin 33 (2) (2017) 259–75. - PubMed
    1. Pipeling MR, Fan E, Therapies for refractory hypoxemia in acute respiratory distress syndrome, J. Am. Med. Assoc 304 (22) (2010) 2521–7. - PubMed
    1. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, et al., Comparison of two fluid-management strategies in acute lung injury, N. Engl. J. Med 354 (24) (2006) 2564–75. - PubMed

MeSH terms